VanEck iBoxx EUR Corporates UCITS ETF
VanEck iBoxx EUR Corporates UCITS ETF TCBT.AS Peers
See (TCBT.AS) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
TCBT.AS | €17.32 | -0.05% | 42.2M | N/A | N/A | +2.02% |
JPSR.AS | €23.55 | -1.31% | 820.6B | N/A | N/A | +2.02% |
IWDA.AS | €99.76 | +0.13% | 91.4B | N/A | N/A | N/A |
VUSA.AS | €99.20 | +0.44% | 56.9B | N/A | N/A | +1.09% |
VWRL.AS | €127.66 | +0.10% | 32.7B | N/A | N/A | +1.59% |
SP5C.PA | €375.42 | +0.51% | 18.2B | 25.87 | €14.51 | N/A |
SP5H.PA | €292.60 | +0.15% | 17.9B | 25.95 | €11.27 | +1.28% |
IUSA.AS | €52.15 | +0.50% | 15.7B | N/A | N/A | +1.08% |
AMUN.PA | €72.40 | -1.76% | 14.7B | 11.37 | €6.37 | +5.66% |
ISFA.AS | €10.25 | -0.56% | 14.5B | N/A | N/A | +3.42% |
Stock Comparison
TCBT.AS vs JPSR.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, JPSR.AS has a market cap of 820.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while JPSR.AS trades at €23.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas JPSR.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to JPSR.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to JPSR.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs IWDA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, IWDA.AS has a market cap of 91.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while IWDA.AS trades at €99.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas IWDA.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to IWDA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to IWDA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs VUSA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, VUSA.AS has a market cap of 56.9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while VUSA.AS trades at €99.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas VUSA.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to VUSA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to VUSA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs VWRL.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, VWRL.AS has a market cap of 32.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while VWRL.AS trades at €127.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas VWRL.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to VWRL.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to VWRL.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs SP5C.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, SP5C.PA has a market cap of 18.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while SP5C.PA trades at €375.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas SP5C.PA's P/E ratio is 25.87. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to SP5C.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to SP5C.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs SP5H.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, SP5H.PA has a market cap of 17.9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while SP5H.PA trades at €292.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas SP5H.PA's P/E ratio is 25.95. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to SP5H.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to SP5H.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs IUSA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, IUSA.AS has a market cap of 15.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while IUSA.AS trades at €52.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas IUSA.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to IUSA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to IUSA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs AMUN.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, AMUN.PA has a market cap of 14.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while AMUN.PA trades at €72.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas AMUN.PA's P/E ratio is 11.37. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to AMUN.PA's ROE of +0.11%. Regarding short-term risk, TCBT.AS is less volatile compared to AMUN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ISFA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ISFA.AS has a market cap of 14.5B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ISFA.AS trades at €10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ISFA.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ISFA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ISFA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs HAL.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, HAL.AS has a market cap of 10.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while HAL.AS trades at €118.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas HAL.AS's P/E ratio is 8.86. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to HAL.AS's ROE of +0.08%. Regarding short-term risk, TCBT.AS is less volatile compared to HAL.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs PSH.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, PSH.AS has a market cap of 9.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while PSH.AS trades at €51.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas PSH.AS's P/E ratio is 4.41. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to PSH.AS's ROE of +0.11%. Regarding short-term risk, TCBT.AS is less volatile compared to PSH.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CSH2.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CSH2.PA has a market cap of 9.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CSH2.PA trades at €106.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CSH2.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CSH2.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is more volatile compared to CSH2.PA. This indicates potentially higher risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs WLD.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, WLD.PA has a market cap of 9.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while WLD.PA trades at €340.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas WLD.PA's P/E ratio is 22.82. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to WLD.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to WLD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs WLDH.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, WLDH.PA has a market cap of 9.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while WLDH.PA trades at €212.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas WLDH.PA's P/E ratio is 22.67. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to WLDH.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to WLDH.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs MEUD.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, MEUD.PA has a market cap of 9.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while MEUD.PA trades at €262.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas MEUD.PA's P/E ratio is 17.49. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to MEUD.PA's ROE of N/A. Regarding short-term risk, TCBT.AS is less volatile compared to MEUD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs IMEU.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, IMEU.AS has a market cap of 9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while IMEU.AS trades at €34.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas IMEU.AS's P/E ratio is 17.70. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to IMEU.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to IMEU.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs GBLB.BR Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, GBLB.BR has a market cap of 8.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while GBLB.BR trades at €71.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas GBLB.BR's P/E ratio is 299.17. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to GBLB.BR's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to GBLB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs SOF.BR Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, SOF.BR has a market cap of 8.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while SOF.BR trades at €249.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas SOF.BR's P/E ratio is 6.21. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to SOF.BR's ROE of +0.14%. Regarding short-term risk, TCBT.AS is less volatile compared to SOF.BR. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs I500.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, I500.AS has a market cap of 7.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while I500.AS trades at €9.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas I500.AS's P/E ratio is 25.69. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to I500.AS's ROE of N/A. Regarding short-term risk, TCBT.AS is less volatile compared to I500.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs GOLD.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, GOLD.PA has a market cap of 7.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while GOLD.PA trades at €115.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas GOLD.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to GOLD.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to GOLD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs I50D.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, I50D.AS has a market cap of 7.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while I50D.AS trades at €6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas I50D.AS's P/E ratio is 25.97. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to I50D.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to I50D.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs LCWD.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, LCWD.PA has a market cap of 7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while LCWD.PA trades at €19.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas LCWD.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to LCWD.PA's ROE of N/A. Regarding short-term risk, TCBT.AS is less volatile compared to LCWD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs IWRD.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, IWRD.AS has a market cap of 6.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while IWRD.AS trades at €72.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas IWRD.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to IWRD.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to IWRD.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ECRP.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ECRP.PA has a market cap of 6.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ECRP.PA trades at €53.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ECRP.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ECRP.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ECRP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CC4.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CC4.PA has a market cap of 6.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CC4.PA trades at €223.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CC4.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CC4.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is more volatile compared to CC4.PA. This indicates potentially higher risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs VHYL.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, VHYL.AS has a market cap of 6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while VHYL.AS trades at €64.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas VHYL.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to VHYL.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to VHYL.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs 500.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, 500.PA has a market cap of 5.8B. Regarding current trading prices, TCBT.AS is priced at €17.32, while 500.PA trades at €103.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas 500.PA's P/E ratio is 25.86. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to 500.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to 500.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs AEME.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, AEME.PA has a market cap of 5.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while AEME.PA trades at €68.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas AEME.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to AEME.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to AEME.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CW8.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CW8.PA has a market cap of 5.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CW8.PA trades at €545.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CW8.PA's P/E ratio is 22.82. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CW8.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to CW8.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs PHAU.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, PHAU.AS has a market cap of 5.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while PHAU.AS trades at €271.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas PHAU.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to PHAU.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to PHAU.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs IJPA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, IJPA.AS has a market cap of 5.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while IJPA.AS trades at €53.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas IJPA.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to IJPA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to IJPA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs KBCA.BR Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, KBCA.BR has a market cap of 4.9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while KBCA.BR trades at €63.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas KBCA.BR's P/E ratio is 13.32. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to KBCA.BR's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to KBCA.BR. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs S500.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, S500.PA has a market cap of 4.8B. Regarding current trading prices, TCBT.AS is priced at €17.32, while S500.PA trades at €147.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas S500.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to S500.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to S500.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs S500H.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, S500H.PA has a market cap of 4.8B. Regarding current trading prices, TCBT.AS is priced at €17.32, while S500H.PA trades at €82.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas S500H.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to S500H.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to S500H.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs VEUR.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, VEUR.AS has a market cap of 4.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while VEUR.AS trades at €43.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas VEUR.AS's P/E ratio is 17.64. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to VEUR.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to VEUR.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs UST.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, UST.PA has a market cap of 4.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while UST.PA trades at €76.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas UST.PA's P/E ratio is 32.90. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to UST.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to UST.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs REINA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, REINA.AS has a market cap of 4.5B. Regarding current trading prices, TCBT.AS is priced at €17.32, while REINA.AS trades at €24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas REINA.AS's P/E ratio is 5.68. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to REINA.AS's ROE of +0.16%. Regarding short-term risk, TCBT.AS is less volatile compared to REINA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EUEA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EUEA.AS has a market cap of 4.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EUEA.AS trades at €55.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EUEA.AS's P/E ratio is 16.95. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EUEA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EUEA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs USAC.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, USAC.PA has a market cap of 4.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while USAC.PA trades at €530.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas USAC.PA's P/E ratio is 31.32. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to USAC.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to USAC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs IEMM.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, IEMM.AS has a market cap of 4.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while IEMM.AS trades at €40.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas IEMM.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to IEMM.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to IEMM.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs USA.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, USA.PA has a market cap of 4.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while USA.PA trades at €489.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas USA.PA's P/E ratio is 30.76. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to USA.PA's ROE of N/A. Regarding short-term risk, TCBT.AS is less volatile compared to USA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs RF.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, RF.PA has a market cap of 4.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while RF.PA trades at €61.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas RF.PA's P/E ratio is -71.16. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to RF.PA's ROE of -0.06%. Regarding short-term risk, TCBT.AS is less volatile compared to RF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs 500X.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, 500X.AS has a market cap of 4.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while 500X.AS trades at €36.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas 500X.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to 500X.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to 500X.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ICHN.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ICHN.AS has a market cap of 4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ICHN.AS trades at €5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ICHN.AS's P/E ratio is 12.68. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ICHN.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ICHN.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs C50U.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, C50U.PA has a market cap of 4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while C50U.PA trades at €158.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas C50U.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to C50U.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to C50U.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CACC.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CACC.PA has a market cap of 4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CACC.PA trades at €38.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CACC.PA's P/E ratio is 17.08. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CACC.PA's ROE of N/A. Regarding short-term risk, TCBT.AS is less volatile compared to CACC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CAC.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CAC.PA has a market cap of 4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CAC.PA trades at €78.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CAC.PA's P/E ratio is 17.01. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CAC.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to CAC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs WSRI.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, WSRI.PA has a market cap of 4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while WSRI.PA trades at €103.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas WSRI.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to WSRI.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to WSRI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ICHD.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ICHD.AS has a market cap of 4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ICHD.AS trades at €4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ICHD.AS's P/E ratio is 12.70. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ICHD.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ICHD.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs MSE.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, MSE.PA has a market cap of 3.8B. Regarding current trading prices, TCBT.AS is priced at €17.32, while MSE.PA trades at €59.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas MSE.PA's P/E ratio is 16.70. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to MSE.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to MSE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs AUEM.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, AUEM.PA has a market cap of 3.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while AUEM.PA trades at €5.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas AUEM.PA's P/E ratio is 13.19. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to AUEM.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to AUEM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs MF.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, MF.PA has a market cap of 3.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while MF.PA trades at €85.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas MF.PA's P/E ratio is -29.23. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to MF.PA's ROE of -0.08%. Regarding short-term risk, TCBT.AS is less volatile compared to MF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs C50.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, C50.PA has a market cap of 3.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while C50.PA trades at €140.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas C50.PA's P/E ratio is 16.64. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to C50.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to C50.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CD5.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CD5.PA has a market cap of 3.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CD5.PA trades at €86.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CD5.PA's P/E ratio is 16.65. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CD5.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to CD5.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ROLA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ROLA.AS has a market cap of 3.5B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ROLA.AS trades at €63.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ROLA.AS's P/E ratio is 6.34. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ROLA.AS's ROE of N/A. Regarding short-term risk, TCBT.AS is more volatile compared to ROLA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ALLFG.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ALLFG.AS has a market cap of 3.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ALLFG.AS trades at €5.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ALLFG.AS's P/E ratio is -19.75. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ALLFG.AS's ROE of -0.09%. Regarding short-term risk, TCBT.AS is less volatile compared to ALLFG.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs VERX.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, VERX.AS has a market cap of 3.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while VERX.AS trades at €43.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas VERX.AS's P/E ratio is 17.49. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to VERX.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to VERX.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs BREB.BR Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, BREB.BR has a market cap of 3.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while BREB.BR trades at €114.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas BREB.BR's P/E ratio is 8.11. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to BREB.BR's ROE of +0.10%. Regarding short-term risk, TCBT.AS is less volatile compared to BREB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs TKO.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, TKO.PA has a market cap of 3.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while TKO.PA trades at €19.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas TKO.PA's P/E ratio is 20.90. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to TKO.PA's ROE of +0.05%. Regarding short-term risk, TCBT.AS is less volatile compared to TKO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs AEEM.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, AEEM.PA has a market cap of 3.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while AEEM.PA trades at €5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas AEEM.PA's P/E ratio is 14.58. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to AEEM.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to AEEM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CB3.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CB3.PA has a market cap of 3.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CB3.PA trades at €221.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CB3.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CB3.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to CB3.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs WESE.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, WESE.PA has a market cap of 3.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while WESE.PA trades at €69.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas WESE.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to WESE.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to WESE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EEUE.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EEUE.PA has a market cap of 3.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EEUE.PA trades at €17.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EEUE.PA's P/E ratio is 18.27. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EEUE.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EEUE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs SEMD.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, SEMD.AS has a market cap of 2.9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while SEMD.AS trades at €5.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas SEMD.AS's P/E ratio is 15.40. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to SEMD.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to SEMD.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EHYA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EHYA.AS has a market cap of 2.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EHYA.AS trades at €5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EHYA.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EHYA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EHYA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EUSRI.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EUSRI.PA has a market cap of 2.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EUSRI.PA trades at €86.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EUSRI.PA's P/E ratio is 22.29. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EUSRI.PA's ROE of N/A. Regarding short-term risk, TCBT.AS is less volatile compared to EUSRI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ESE.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ESE.PA has a market cap of 2.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ESE.PA trades at €26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ESE.PA's P/E ratio is 25.86. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ESE.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ESE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs GEMU.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, GEMU.PA has a market cap of 2.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while GEMU.PA trades at €9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas GEMU.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to GEMU.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is more volatile compared to GEMU.PA. This indicates potentially higher risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EPAB.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EPAB.PA has a market cap of 2.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EPAB.PA trades at €36.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EPAB.PA's P/E ratio is 17.39. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EPAB.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EPAB.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs TNOW.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, TNOW.PA has a market cap of 2.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while TNOW.PA trades at €801.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas TNOW.PA's P/E ratio is 37.74. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to TNOW.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to TNOW.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs TDIV.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, TDIV.AS has a market cap of 2.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while TDIV.AS trades at €43.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas TDIV.AS's P/E ratio is 11.49. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to TDIV.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to TDIV.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EXCH.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EXCH.AS has a market cap of 2.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EXCH.AS trades at €5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EXCH.AS's P/E ratio is 15.36. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EXCH.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EXCH.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs USRI.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, USRI.PA has a market cap of 2.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while USRI.PA trades at €102.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas USRI.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to USRI.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to USRI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ANX.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ANX.PA has a market cap of 2.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ANX.PA trades at €216.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ANX.PA's P/E ratio is 32.89. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ANX.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ANX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs PABW.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, PABW.PA has a market cap of 2.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while PABW.PA trades at €76.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas PABW.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to PABW.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to PABW.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ANTIN.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ANTIN.PA has a market cap of 1.9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ANTIN.PA trades at €10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ANTIN.PA's P/E ratio is 16.55. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ANTIN.PA's ROE of +0.27%. Regarding short-term risk, TCBT.AS is less volatile compared to ANTIN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CMUD.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CMUD.PA has a market cap of 1.9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CMUD.PA trades at €67.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CMUD.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CMUD.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to CMUD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs BNKE.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, BNKE.PA has a market cap of 1.9B. Regarding current trading prices, TCBT.AS is priced at €17.32, while BNKE.PA trades at €241.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas BNKE.PA's P/E ratio is 9.36. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to BNKE.PA's ROE of N/A. Regarding short-term risk, TCBT.AS is less volatile compared to BNKE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs PEUG.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, PEUG.PA has a market cap of 1.8B. Regarding current trading prices, TCBT.AS is priced at €17.32, while PEUG.PA trades at €74.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas PEUG.PA's P/E ratio is 12.64. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to PEUG.PA's ROE of +0.03%. Regarding short-term risk, TCBT.AS is less volatile compared to PEUG.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ACWI.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ACWI.PA has a market cap of 1.8B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ACWI.PA trades at €470.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ACWI.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ACWI.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ACWI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EGOV.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EGOV.PA has a market cap of 1.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EGOV.PA trades at €49.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EGOV.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EGOV.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EGOV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs PHAG.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, PHAG.AS has a market cap of 1.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while PHAG.AS trades at €26.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas PHAG.AS's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to PHAG.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to PHAG.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs MUSD.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, MUSD.AS has a market cap of 1.7B. Regarding current trading prices, TCBT.AS is priced at €17.32, while MUSD.AS trades at €8.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas MUSD.AS's P/E ratio is 26.20. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to MUSD.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to MUSD.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs GIMB.BR Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, GIMB.BR has a market cap of 1.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while GIMB.BR trades at €45.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas GIMB.BR's P/E ratio is 6.10. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to GIMB.BR's ROE of +0.13%. Regarding short-term risk, TCBT.AS is less volatile compared to GIMB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs WAT.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, WAT.PA has a market cap of 1.6B. Regarding current trading prices, TCBT.AS is priced at €17.32, while WAT.PA trades at €68.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas WAT.PA's P/E ratio is 28.63. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to WAT.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to WAT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs MPAB.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, MPAB.AS has a market cap of 1.5B. Regarding current trading prices, TCBT.AS is priced at €17.32, while MPAB.AS trades at €5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas MPAB.AS's P/E ratio is 17.26. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to MPAB.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to MPAB.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EMPA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EMPA.AS has a market cap of 1.5B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EMPA.AS trades at €6.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EMPA.AS's P/E ratio is 17.29. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EMPA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EMPA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EGRI.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EGRI.PA has a market cap of 1.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EGRI.PA trades at €45.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EGRI.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EGRI.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EGRI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs CG1.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, CG1.PA has a market cap of 1.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while CG1.PA trades at €427.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas CG1.PA's P/E ratio is 18.45. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to CG1.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to CG1.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs AASI.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, AASI.PA has a market cap of 1.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while AASI.PA trades at €38.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas AASI.PA's P/E ratio is 15.11. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to AASI.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to AASI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs LWCR.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, LWCR.PA has a market cap of 1.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while LWCR.PA trades at €498.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas LWCR.PA's P/E ratio is N/A. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to LWCR.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to LWCR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs INR.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, INR.PA has a market cap of 1.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while INR.PA trades at €29.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas INR.PA's P/E ratio is 24.52. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to INR.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to INR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs BNK.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, BNK.PA has a market cap of 1.4B. Regarding current trading prices, TCBT.AS is priced at €17.32, while BNK.PA trades at €45.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas BNK.PA's P/E ratio is 9.65. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to BNK.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to BNK.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs EXA1.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, EXA1.AS has a market cap of 1.3B. Regarding current trading prices, TCBT.AS is priced at €17.32, while EXA1.AS trades at €12.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas EXA1.AS's P/E ratio is 9.39. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to EXA1.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to EXA1.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs DAX.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, DAX.PA has a market cap of 1.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while DAX.PA trades at €219.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas DAX.PA's P/E ratio is 18.45. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to DAX.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to DAX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs WQDA.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, WQDA.AS has a market cap of 1.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while WQDA.AS trades at €9.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas WQDA.AS's P/E ratio is 17.83. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to WQDA.AS's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to WQDA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ESGE.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ESGE.PA has a market cap of 1.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ESGE.PA trades at €34.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ESGE.PA's P/E ratio is 18.85. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ESGE.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ESGE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs ESGH.PA Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, ESGH.PA has a market cap of 1.2B. Regarding current trading prices, TCBT.AS is priced at €17.32, while ESGH.PA trades at €25.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas ESGH.PA's P/E ratio is 18.79. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to ESGH.PA's ROE of +0.00%. Regarding short-term risk, TCBT.AS is less volatile compared to ESGH.PA. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.
TCBT.AS vs TFG.AS Comparison
TCBT.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCBT.AS stands at 42.2M. In comparison, TFG.AS has a market cap of 1.1B. Regarding current trading prices, TCBT.AS is priced at €17.32, while TFG.AS trades at €14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCBT.AS currently has a P/E ratio of N/A, whereas TFG.AS's P/E ratio is 3.58. In terms of profitability, TCBT.AS's ROE is +0.00%, compared to TFG.AS's ROE of +0.12%. Regarding short-term risk, TCBT.AS is less volatile compared to TFG.AS. This indicates potentially lower risk in terms of short-term price fluctuations for TCBT.AS.